
Benzinga Pro data, OptiNose (NASDAQ:OPTN) reported Q1 sales of $14.76 million. Earnings fell to a loss of $25.33 million, resulting in a 62.14% decrease from last quarter. OptiNose collected $22.51 million in revenue during Q4, but reported earnings showed a $15.62 million loss.